BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: HerbVic who wrote (238)	6/7/2000 2:58:00 AM
From: tuck	Read Replies (1) of 253

Herb, Thanks for your thoughts. I, too, question the acceptance of INTACs. However, though the price advantage for them has eroded compared to LASIK, they're reversible and less risky. An eye doctor friend of mine tells me that reversibility is a big issue with her patients. One doc in town does include INTACs in his arsenal, and I might very well make an appointment with him, and see what I can ferret out. My eyes are probably close to OK, but hopefully, if I'm paying for his time, he'll discuss it with me even of I'm not a candidate for treatment. I will certainly post that info, but it may be a while before I can set it up. I used to like STAA, but I think management has somewhat overstated their market. See the thread for my thoughts on that. Talk about being a lonely poster. I replied to everyone and got nothing! Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next